Analyses of myocardial epitopes and apoptosis with treatment of peptide therapy in myocarditis.
心肌炎肽疗法治疗心肌表位和细胞凋亡的分析。
基本信息
- 批准号:09470164
- 负责人:
- 金额:$ 5.57万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To clarify the pathogenesis and the development of coxsackievirus B3 (CVB3) myocarditis, we examined the histopathology of CVB3-inoculated wild type and severe combined immunodeficient C3H/He mice, and analyzed using subcloning method the sequence of nucleotides of an amyocarditic strain of CVB3 (CVBO) with comparison of that of a myocarditic strain of CVB3 (CVBM), which was already reported. Severe myocarditis developed in wild mice inoculated with CVBM.On the contrary, mild myocarditis resulted from wild mice inoculated with CVBO.In scid mice, severe myocarditis developed by the inoculation of both CVBM and CVBO.There were seven nucleotide differences with five corresponding amino acid changes in the sequence of CVBO in comparison with that of CVBM.The changes located in 1A, 1C, and 1D regions of viral genome, which encoded the envelope protein. Thus, antigenic determinant of CVB3 is related, at least in part, to the recognition of immunocompetent cells to the difference of nucleotides in these regions. In conclusion, the development of myocarditis is related to the immunological background of the host, and myocarditis is due, in part, to an immunopathogenic phenomenon.
为阐明柯萨奇病毒B3(CVB 3)心肌炎的发病机制和发展过程,我们观察了CVB 3感染野生型和严重联合免疫缺陷C3 H/He小鼠的组织病理学变化,并采用亚克隆技术对CVB 3心肌炎株(CVBO)和已报道的CVB 3心肌炎株(CVBM)的核苷酸序列进行了比较分析。结果表明,CVBO与CVBM相比,在1A、1C和1D区有7个核苷酸的差异,其中5个氨基酸发生了相应的变化,而在1B区有5个氨基酸的变化,其中1A区的变化最明显,1C区的变化最明显,1D区的变化最明显,1B区的变化最明显,1C区的变化最明显,1D区的变化最明显,1A区的变化最明显,1C区的变化最明显,1D区的变化最明显,1C区的变化最明显,1D区的变化最明显。它编码包膜蛋白。因此,CVB 3的抗原决定簇至少部分地与免疫活性细胞对这些区域中核苷酸差异的识别有关。总之,心肌炎的发展与宿主的免疫背景有关,心肌炎部分是由于免疫病理现象。
项目成果
期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shioji K,Kishimoto C,Nakayama Y,Sasayama S: "Strain difference in rats with experimental giant cell myocarditis"Jpn Circ J. 64. 283-286 (2000)
Shioji K、Kishimoto C、Nakayama Y、Sasayama S:“实验性巨细胞心肌炎大鼠的应变差异”Jpn Circ J. 64. 283-286 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kishimoto C,Kuroki Y,Kurokawa M,Ochiai H.: "Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis" Basic Res in Cardiol. 92. 4022-4029 (1997)
Kishimoto C、Kuroki Y、Kurokawa M、Ochiai H.:“小鼠柯萨奇病毒 B3 心肌炎中的淋巴因子激活的杀伤细胞”Cardiol 中的基础研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kishimoto C.: "Intravenous IgG: Supertherapy for myocarditis and acute DCM." Circulation. 99. 975 (1999)
Kishimoto C.:“静脉注射 IgG:心肌炎和急性 DCM 的超级疗法。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
岸本千晴: "ガンマグロブリンの心筋炎に対する効果 特集:川崎病" Prog.Med 第22回近畿川崎病研究会, 1577-1581 (1988)
Chiharu Kishimoto:“丙种球蛋白对心肌炎的影响专题:川崎病”Prog.Med第22届近畿川崎病研究组,1577-1581(1988)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KISHIMOTO Chiharu其他文献
KISHIMOTO Chiharu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KISHIMOTO Chiharu', 18)}}的其他基金
Myocardial regeneration by redox regulation in myocarditis with heart failure
心力衰竭心肌炎中氧化还原调节的心肌再生
- 批准号:
18590772 - 财政年份:2006
- 资助金额:
$ 5.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Treatment for myocarditis with heart failure by the inhibitory Fc receptor of immunoglobulin
免疫球蛋白抑制性Fc受体治疗心肌炎心力衰竭
- 批准号:
14570656 - 财政年份:2002
- 资助金额:
$ 5.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myocardial damage by cultured autologous lymphocytes with IL-2 in viral myocarditis
IL-2培养自体淋巴细胞对病毒性心肌炎的心肌损伤
- 批准号:
06670702 - 财政年份:1994
- 资助金额:
$ 5.57万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Antibody-mediated infection and cytotoxic T cells in cosackievirus B3 myocarditis
科萨基病毒 B3 心肌炎中抗体介导的感染和细胞毒性 T 细胞
- 批准号:
03670445 - 财政年份:1991
- 资助金额:
$ 5.57万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
The in Vivo Significance of T Cells in Coxsackievirus B3 Myocarditis
T 细胞在柯萨奇病毒 B3 心肌炎中的体内意义
- 批准号:
01570478 - 财政年份:1989
- 资助金额:
$ 5.57万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Decoding Dilated Cardiomyopathy in vitro: Linking Genetic Mutations to Phenotypic Dysfunction
体外解码扩张型心肌病:将基因突变与表型功能障碍联系起来
- 批准号:
495567 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Miscellaneous Programs
Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families (DCM Next)
促进扩张型心肌病患者和家庭的诊断、患者分层和治疗取得进展 (DCM Next)
- 批准号:
10085929 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
EU-Funded
Evaluating sex specific differences in dilated cardiomyopathy
评估扩张型心肌病的性别特异性差异
- 批准号:
MR/W023830/1 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Fellowship
Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy
使用 miRNA 确定扩张型心肌病的新治疗途径
- 批准号:
10740082 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Dysregulated mechanosignaling in dilated cardiomyopathy caused by defective Filamin C
Filamin C 缺陷引起的扩张型心肌病的机械信号失调
- 批准号:
10877387 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Development of strategies to enhance titin (TTN) expression and treat dilated cardiomyopathy caused by TTN haploinsufficiency
开发增强肌联蛋白 (TTN) 表达并治疗 TTN 单倍体不足引起的扩张型心肌病的策略
- 批准号:
10662742 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Elucidation of pathogenesis mechanisms and exploration of therapeutic strategies using mouse models of dilated cardiomyopathy
扩张型心肌病小鼠模型阐明发病机制并探索治疗策略
- 批准号:
23K18221 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank Analysis
通过大规模生物库分析发现和表征扩张型心肌病的罕见变异效应
- 批准号:
10682290 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Elucidation of Molecular Basis for Myocardial Fibrosis in Dilated Cardiomyopathy
扩张型心肌病心肌纤维化的分子基础阐明
- 批准号:
23K15174 - 财政年份:2023
- 资助金额:
$ 5.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists